SCHEMBL23320751

SCHEMBL23320751

c1cnc2c(c1)cc(-c1nc(-n3c4ccccc4c4cccnc43)nc(-n3c4ccccc4c4cccnc43)n1)c1cccnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.42
CCR8 P51685 5/20 0.42
L3MBTL1 Q9Y468 4/20 0.42
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
CCR5 P51681 3/20 0.34
KDM4E B2RXH2 3/20 0.34
TSHR P16473 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 2/20 0.34
HSP90AA1 P07900 2/20 0.34
GMNN O75496 1/20 0.34
TP53 P04637 1/20 0.34
MMP2 P08253 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MMP9 P14780 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34
MMP8 P22894 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23321272 0.99 CCR1 (0.41) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23322782 0.95 ALDH1A1 (0.44) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23322534 0.94 ALDH1A1 (0.43) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23322784 0.94 CCR1 (0.35) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23322535 0.93 CCR1 (0.35) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23321486 0.92 CCR1 (0.46) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23321181 0.91 ALDH1A1 (0.43) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23321360 0.90 CCR1 (0.35) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23322805 0.89 CCR1 (0.46) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL23320795 0.88 CCR1 (0.43) CCR1CCR8L3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130355-A1 COMPOUND, ELECTRON TRANSPORT MATERIAL, DISPLAY PANEL AND DISPLAY APPARATUS Shanghai Tianma AM-OLED Co., Ltd. (CN) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130355-A1 COMPOUND, ELECTRON TRANSPORT MATERIAL, DISPLAY PANEL AND DISPLAY APPARATUS KCNQ4, TRPC4, KCNQ1 CCR1 991/4885CCR8 1925/4885L3MBTL1 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.